These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study.
    Author: Kertesz DP, Swartz MV, Tadger S, Plopski I, Barak Y.
    Journal: Clin Neuropharmacol; 2015; 38(1):23-5. PubMed ID: 25580924.
    Abstract:
    Tardive tremor (TT) is a rare neuroleptic-induced tardive syndrome. It is mainly postural and action associated rather than resting tremor without other parkinsonian features and resistant to most therapeutic interventions. Tetrabenazine (TBZ) is a possible option for treating TT.This study aimed to evaluate the efficacy and tolerability of TBZ in elderly patients with TT. Patients (N = 10) received TBZ (25-150 mg/d) for 6 weeks. Five subjects completed the study. Mean TBZ dose at study end was 57.5 ± 37.3 mg/d. Mean Abnormal Involuntary Movement score was 13.3 ± 6.6, mean Tremor Scale score was 2.3 ± 0.9, mean Clinical Global Impression-Change was 3.6 ± 2.2, and mean Geriatric Depression Score was 5.2 ± 4.9; all not significantly changed from baseline. Five patients suffered side effects, including depression (n = 3), parkinsonism (n = 2), akathisia (n = 1), and mild stroke (n = 1).This prospective study does not support TBZ treatment for TT in elderly psychiatric patients.
    [Abstract] [Full Text] [Related] [New Search]